SCHEMBL21155384

SCHEMBL21155384

c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4c5ccccc5c5c6ccncc6n(-c6ccccc6)c5c43)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
AOC3 Q16853 2/20 0.34
KCNH2 Q12809 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPT P10636 1/20 0.33
TOP2A P11388 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
GLA P06280 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
CDK4 P11802 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19988750 0.98 DYRK1A (0.39) DYRK1AAOC3KCNH2MEN1KMT2A
SCHEMBL24767864 0.91 KDM4E (0.35) DYRK1AKDM4EATML3MBTL1MEN1
SCHEMBL14900857 0.90 L3MBTL1 (0.44) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL21397973 0.89 KDM4E (0.41) DYRK1AKDM4EATML3MBTL1AOC3
SCHEMBL21398001 0.89 KDM4E (0.41) DYRK1AKDM4EATML3MBTL1AOC3
SCHEMBL19988625 0.88 MAPT (0.37) DYRK1AAOC3KCNH2MEN1KMT2A
SCHEMBL22200016 0.87 L3MBTL1 (0.42) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL17349101 0.87 DYRK1A (0.39) DYRK1AKDM4EATML3MBTL1AOC3
SCHEMBL21397986 0.86 KDM4E (0.39) DYRK1AKDM4EATML3MBTL1AOC3
SCHEMBL19988693 0.86 ABCG2 (0.44) KDM4EMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 DYRK1A 3310/4885KDM4E 2638/4885ATM 3761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.